Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity

[1]  SoJung Lee,et al.  25-Hydroxyvitamin D in Obese Youth Across the Spectrum of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes , 2013, Diabetes Care.

[2]  S. Abrams,et al.  Vitamin D: effects on childhood health and disease , 2013, Nature Reviews Endocrinology.

[3]  T. Spector,et al.  Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts , 2013, PLoS medicine.

[4]  H. Ou,et al.  Plasma 25-Hydroxyvitamin D Levels Are Favorably Associated With &bgr;-Cell Function , 2012, Pancreas.

[5]  E. Kalkhoven,et al.  Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes , 2012, Diabetologia.

[6]  O. Mäkitie,et al.  Vitamin D Is a Major Determinant of Bone Mineral Density at School Age , 2012, PloS one.

[7]  H. Vader,et al.  The new Roche Vitamin D Total assay: fit for its purpose? , 2012, Clinical chemistry and laboratory medicine.

[8]  C. Lamendola,et al.  Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. , 2012, The American journal of clinical nutrition.

[9]  C. Levy-marchal,et al.  Novel Modeling of Reference Values of Cardiovascular Risk Factors in Children Aged 7 to 20 Years , 2012, Pediatrics.

[10]  S. Salekzamani,et al.  Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  J. Shaw,et al.  Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). , 2012, The Journal of clinical endocrinology and metabolism.

[12]  N. Çelik,et al.  Vitamin D Deficiency in Children and Adolescents , 2012, Journal of clinical research in pediatric endocrinology.

[13]  D. Egan,et al.  Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[14]  P. White,et al.  Vitamin D deficiency in obese children and its relationship to glucose homeostasis. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  Stef van Buuren,et al.  Increase in Prevalence of Overweight in Dutch Children and Adolescents: A Comparison of Nationwide Growth Studies in 1980, 1997 and 2009 , 2011, PloS one.

[16]  E. Ingelsson,et al.  Association between serum cathepsin S and mortality in older adults. , 2011, JAMA.

[17]  M. Borggrefe,et al.  1α,25-Dihydroxyvitamin D3 Attenuates Platelet Activation and the Expression of VCAM-1 and MT1-MMP in Human Endothelial Cells , 2011, Cardiology.

[18]  P. Ducy.  The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism , 2011, Diabetologia.

[19]  C. Sempos,et al.  Vitamin D status: United States, 2001-2006. , 2011, NCHS data brief.

[20]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[21]  Matthew C. Ernst,et al.  Chemerin: at the crossroads of inflammation and obesity , 2010, Trends in Endocrinology & Metabolism.

[22]  J. Mitri,et al.  Shining a light : the role of vitamin D in diabetes mellitus , 2022 .

[23]  E. Kalkhoven,et al.  A multiplex immunoassay for human adipokine profiling. , 2010, Clinical chemistry.

[24]  M. Hiltz,et al.  Addressing vitamin D deficiency in Canada: a public health innovation whose time has come. , 2010, Public health.

[25]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[26]  S. Hailpern,et al.  Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004 , 2009, Pediatrics.

[27]  V. Quesada,et al.  Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. , 2009, The Journal of clinical investigation.

[28]  J. Mora,et al.  Vitamin effects on the immune system: vitamins A and D take centre stage , 2008, Nature Reviews Immunology.

[29]  M. Misra,et al.  Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations , 2008, Pediatrics.

[30]  Setting Brazil.  Establishing a standard definition for child overweight and obesity worldwide: international survey. , 2008 .

[31]  Elena Galkina,et al.  Vascular adhesion molecules in atherosclerosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[32]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[33]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[34]  K. Clément,et al.  Emerging role of cathepsin S in obesity and its associated diseases , 2007, Clinical chemistry and laboratory medicine.

[35]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[36]  S. van Buuren,et al.  Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? , 2005, European Journal of Pediatrics.

[37]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[38]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[39]  J. Janosky,et al.  Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. , 2004, The Journal of pediatrics.

[40]  Hideki Nakamura,et al.  Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus. , 2002, Diabetes research and clinical practice.

[41]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[42]  C. López-Otín,et al.  Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases. , 1994, The Journal of biological chemistry.